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Abstract
Background:  Viral infections and exposure to oxidant air pollutants are two of the most
important inducers of asthma exacerbation. Our previous studies have demonstrated that
exposure to diesel exhaust increases the susceptibility to influenza virus infections both in epithelial
cells in vitro and in mice in vivo. Therefore, we examined whether in the setting of allergic asthma,
exposure to oxidant air pollutants enhances the susceptibility to respiratory virus infections, which
in turn leads to increased virus-induced exacerbation of asthma. Ovalbumin-sensitized (OVA) male
C57BL/6 mice were instilled with diesel exhaust particles (DEP) or saline and 24 hours later
infected with influenza A/PR/8. Animals were sacrificed 24 hours post-infection and analyzed for
markers of lung injury, allergic inflammation, and pro-inflammatory cytokine production.
Results: Exposure to DEP or infection with influenza alone had no significant effects on markers
of injury or allergic inflammation. However, OVA-sensitized mice that were exposed to DEP and
subsequently infected with influenza showed increased levels of eosinophils in lung lavage and
tissue. In addition Th2-type cytokines, such as IL-4 and IL-13, and markers of eosinophil
chemotaxis, such as CCL11 and CCR3, were increased in OVA-sensitized mice exposed to DEP
prior to infection with influenza. These mice also showed increased levels of IL-1α, but not IL-10,
RANTES, and MCP-1 in lung homogenates.
Conclusion: These data suggest that in the setting of allergic asthma, exposure to diesel exhaust
could enhance virus-induced exacerbation of allergic inflammation.
Background
The prevalence of allergic diseases, such as asthma, con-
tinues to be on the rise in developed countries. While
genetic components most certainly account for some of
the susceptibility of developing asthma, the increased
prevalence of allergic airway diseases cannot be com-
pletely explained on the basis of genetics. A number of
extrinsic factors, including nutrition, exposure to environ-
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mental pollutants, and lack of exposure to a variety of
pathogens during childhood are also suspected to contrib-
ute to the susceptibility of developing asthma later on in
life as well as the severity of the disease [1]. Moreover,
there are a number of triggers that can exacerbate the dis-
ease and lead to acute allergic inflammation of the air-
ways. Epidemiologic studies have repeatedly
demonstrated that exposure to particulate air pollutants is
associated with exacerbation of asthma and increased
medication use [2,3]. While there have been a number of
very interesting findings regarding potential roles for
chronic exposure to diesel exhaust (DE), such as acting as
an adjuvant or enhancing the development of allergic air-
way disease [4-6], it is not yet clear how acute exposure to
DE could lead to exacerbation of asthma. In a number of
murine models of allergic asthma, exposure to DEP
increased airway obstruction and enhanced allergen-
dependent and independent airway responsiveness [7-9].
However, human studies examining inflammatory mark-
ers in the airways of asthmatics and non-asthmatics have
demonstrated that short-term exposure to DE does not
worsen pre-existing allergic airway inflammation [10]. It
has been suggested that exposure to DE lowers the
immune activation threshold for inducing asthmatic
symptoms, and therefore increases the susceptibility to
exacerbation of the disease [11]. For example, bronchial
epithelial cells obtained from asthmatics constitutively
expressed higher levels of IL-8, GM-CSF, RANTES, and
sICAM and were more sensitive to DEP-induced inflam-
matory mediator production as compared to non-asth-
matic controls [12,13]. In addition, DEP enhanced the
activation of T cells obtained from asthmatics, but not
from non-asthmatic controls [11].
While exposure to air pollutants such as DE can exacer-
bate asthma, the majority of clinically documented
asthma exacerbations are associated with viral infections
[14]. Specifically, rhinovirus (RV) is the most common
virus detected in asthmatics during exacerbations, but the
spectrum of viruses also includes influenza virus, espe-
cially during epidemics [14,15]. Viral respiratory tract
infection-induced acute exacerbations of asthma lead to
increased health care utilization including hospitalization
[16]. In a series of adults hospitalized with asthma, influ-
enza was reported to make up 60% of cases in which a res-
piratory pathogen was isolated using tissue culture
methods [17]. Thus, while not as common as RV in
asthma exacerbations, influenza may account for a rela-
tively high proportion of severe cases, and is therefore rel-
evant from clinical and public health perspectives. The
mechanisms mediating virus-induced exacerbation of
asthma are derived from a number of in vitro models as
well as experimental human infections with rhinovirus
[18]. In addition, a number of animal models have been
developed, including models examining the role of influ-
enza in virus-induced asthma exacerbation [19]. The phe-
notype of virus-induced aggravation of allergic asthma
includes increased eosinophilia, increased Th2-type
immune response, and increase airway hyperreactivity
[19].
Our previous studies have demonstrated that exposure to
DE increases the susceptibility to influenza virus infec-
tions both in epithelial cells in vitro and in mice in vivo and
that this response is mediated by oxidative stress [20,21].
Recent epidemiologic evidence suggests that personal
exposure to oxidant air pollutants increases the severity of
virus-induced asthma exacerbations [22]. These observa-
tions suggest an additive or synergistic interaction
between oxidant air pollution exposure and virus-induced
exacerbation of asthma. The study described here investi-
gated whether and how acute exposure to DEP prior to
infection with influenza virus affects exacerbation of aller-
gic inflammation in a murine model of asthma. Our
results demonstrate that in our model exposure to DEP
prior to infection with influenza resulted in significant
enhancement of allergic airways inflammation, while
either treatment alone did not.
Results
Exposure to DEP prior to infection with influenza 
increases markers of inflammation and lung injury
C57BL/6 male mice were sensitized and challenged with
OVA, then challenged with Influenza (Flu), DEP, or saline
as shown in Fig. 1. Histological examination of overall
inflammation and infiltration of inflammatory cells was
performed, which demonstrated that accumulation of
inflammatory cells was greatest in the DEP/Flu group of
animals (Fig. 2A). In addition, levels of protein in the BAL
fluid (BALF), a marker of edema, were measured. Fig. 2B
shows that exposure to DEP prior to infection with influ-
Schematic of experimental protocol, indicating times of OVA  challenge, DEP-exposure, and virus infection Figure 1
Schematic of experimental protocol, indicating times 
of OVA challenge, DEP-exposure, and virus infection.Particle and Fibre Toxicology 2009, 6:22 http://www.particleandfibretoxicology.com/content/6/1/22
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enza significantly increased BALF protein levels. Neither
exposure to DEP or infection with influenza alone signif-
icantly increased BALF protein.
Exposure to DEP prior to infection with influenza 
increases the number of eosinophils in bronchoalveolar 
lavage
Total and differential cells counts were assessed in BALF of
all four experimental groups. Figure 3A shows that the
number of total recoverable cells in the BALF was only sig-
nificantly enhanced in animals exposed to DEP prior to
infection with influenza. Differential cell counts shown in
Fig. 3B demonstrate that animals exposed to DEP prior to
infection with influenza had significantly higher levels of
eosinophils, while the number of any other cell type in
the BALF did not significantly differ among the experi-
mental groups. Representative images supporting the
large increase of eosinophils in the BALF of animals
exposed to DEP prior to infection with influenza (DEP/
Flu) are shown in Fig. 3C. However, no changes in cell dif-
ferentials were observed in peripheral blood leukocytes
(Table 1).
Exposure to DEP prior to infection with influenza 
increases the number of lung tissue eosinophils
To further assess eosinophil infiltration into the lung,
lung sections were stained using a Carbol Chromotrope to
identify eosinophils. Average numbers of tissue eosi-
nophils located around small airways (150–200 μm lumi-
nal diameter) and blood vessels (10–50 μm luminal
diameter) are shown in Fig. 4A. Similar to eosinophils
numbers in BALF, tissue eosinophils were significantly
elevated in animals exposed to DEP prior to infection with
influenza. Representative images of Carbol Chromotrope
stained sections for airways (4B+C) and blood vessels
(4D+E) from the DEP/Flu group of animals are shown in
Fig. 4B–E.
Effects of exposure to DEP prior to infection with 
influenza on markers of eosinophils recruitment
Eosinophil recruitment into the lung is controlled by the
release of specific chemokines and expression of their
respective receptors on the surface of eosinophils. CCR3 is
highly expressed on eosinophils in both humans and
mice and mediates chemotaxis and recruitment of eosi-
nophils into the lung [23]. CCR3 binds a number of dif-
ferent chemokines, including eotaxin 1, 2, and 3 (CCL 11,
24, and 26 respectively), as well as MCP-2, 3, and 4 (CCL
8, 7, and 13) and RANTES (CCL5) [23], with CCL11 being
more specifically involved in eosinophils recruitment into
the lung. Fig. 5A shows that expression of CCL11 was sig-
nificantly elevated in OVA-sensitized mice exposed to
DEP prior to infection with influenza. Similarly, expres-
sion of CCR3 was significantly enhanced in the DEP/Flu
experimental group as shown in Fig. 5B. Interestingly nei-
ther exposure to DEP or infection with influenza alone
had any significant effect on the expression of CCL11 or
CCR3 in OVA-sensitized mice.
Effects of exposure to DEP prior to infection with 
influenza on inflammatory cytokine expression
Next the effects of DEP prior to infection with influenza in
OVA-sensitized mice on the expression of inflammatory
cytokines were examined, with a specific focus on TH2
cytokines, including IL-13 and IL-4. Fig. 6A shows that the
level of IL-13 in BALF was significantly enhanced in ani-
mals exposed to DEP prior to infection with influenza.
Exposure to DEP or infection with influenza alone
resulted in a small, but not statistically significant
enhancement of IL-13. Similarly, Fig. 6B shows that levels
Analysis of lung injury Figure 2
Analysis of lung injury. A.) Histochemical analysis of lungs 
from OVA-sensitized mice exposed to DEP and/or influenza 
A 24 hours post-infection. Pictures illustrate representative 
hematoxylin-and eosin (H&E)-stained lung sections. Mice 
exposed to DEP and infected with influenza A displayed 
increased cellular infiltration around the blood vessels and 
airways. B.) Protein levels in BALF obtained from OVA-sensi-
tized mice exposed to DEP and/or influenza A 24 hours post-
infection. *significantly different from Sal/Sal group; p < 0.05Particle and Fibre Toxicology 2009, 6:22 http://www.particleandfibretoxicology.com/content/6/1/22
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of IL-4 in lung homogenates (BALF IL-4 levels were below
the detection limit; data not shown), were significantly
enhanced in animals exposed to DEP prior to infection
with influenza. Both IL-4 and IL-13 bind to the alpha
chain of the IL-4 receptor (IL-4Rα). Fig. 6C shows that
expression of IL-4Rα was significantly increased in ani-
mals exposed to DEP prior to infection with influenza.
Taken together, these data show that in OVA-sensitized
mice, exposure to DEP prior to infection with influenza
enhanced the expression of the TH2 cytokines IL-4 and IL-
13 and their common receptor IL-4Rα. In addition, a
number of other cytokines with known roles in either
DEP-induced inflammation or influenza-induced
responses were examined in lung homogenates. Table 2
summarizes these results and demonstrates that there
were no changes in any groups in the levels of IL-10, MCP-
1, and RANTES in lung homogenates. However, IL-1α lev-
els were significantly enhanced in OVA-sensitized animals
exposed to DEP prior to infection with influenza.
Effects of DEP and influenza virus infection on OVA-
specific antibody levels
The OVA sensitization and challenge model used here will
result in OVA-specific antibody formation. To determine
whether exposure to DEP, infection with influenza, or
exposure to DEP prior to infection with influenza affected
OVA-specific antibody levels, we examined OVA-specific
IgG2c, IgE, and IgG1 levels in sera from mice. Table 3
shows that exposure to DEP, infection with influenza, or
the combination treatment had no significant effects on
OVA-specific IgG2c or IgG1 levels. OVA-specific IgE levels
were elevated in animals exposed to DEP alone, influenza
alone, and DEP prior to infection with influenza as com-
pared to the control group (Sal/Sal), albeit not statistically
significant.
Effects of DEP on influenza viral titers
Next, we examined whether in OVA-sensitized mice, a sin-
gle instillation of DEP enhanced influenza viral titers in
the lung. Influenza viral titers were measured at the time
of characterization of allergic inflammation (18 h post-
viral inoculation) by using the TCID50 assay. As shown in
Fig 7, a trend towards greater viral titers was seen in the
DEP-treated group (P = 0.07), even at this early-time point
post-inoculation.
Discussion
Respiratory virus infections are by far the greatest risk fac-
tor for exacerbation of asthma, especially in children.
Considering that concurrent exposures to air pollutants,
such as DE, and respiratory viruses are likely, additive or
synergistic effects between these exposures in individuals
with preexisting allergic airways disease could be of
potential public health significance. Although exposure to
DE or DEP alone can induce a number of adverse immu-
nological effects including increased inflammatory
cytokine production, the effects of DE or DEP have been
repeatedly shown to be much greater in conjunction with
another immunological stimulus. Our previous work has
demonstrated that exposure to DE or DEP increases the
susceptibility to influenza virus infections [20,21] Simi-
larly, a number of studies have demonstrated that expo-
sure to DE or DEP increases sensitization to experimental
allergens such as ovalbumin [9,24,25]. Our study was
designed to test whether and how virus-induced exacerba-
tion of allergic airway inflammation is affected by expo-
sure to oxidant air pollutants. Specifically, we examined
how exposure to DEP prior to infection with influenza
virus modifies markers of allergic inflammation in a
murine model of asthma. Our data shown here demon-
strate that in mice with allergic airway disease, exposure to
DEP prior to infection with influenza increases the
number of lung eosinophils, markers of eosinophils
chemotaxis, and TH2 cytokine levels, while exposure to
DEP or infection with influenza alone did not. These data
indicate that exposure to DEP could potentially sensitize
the lung to virus-induced exacerbation of allergic airways
inflammation.
Compelling epidemiologic evidence that exposure to oxi-
dant air pollutants can enhance the severity of virus-
induced asthma exacerbations comes from a study con-
Table 1: Peripheral blood differential leukocyte count.
Monocytic Cells Neutrophils Lymphocytes Eosinophils
Sal/Sal 8.70 +1.08
(n = 5)
59.50+6.05
(n = 5)
31.80+6.88
(n = 5)
6.40+1.76
(n = 5)
DEP/Sal 10.40+1.85
(n = 5)
49.90+5.37
(n = 5)
39.70+4.07
(n = 5)
8.50+1.76
(n = 5)
Sal/Flu 8.80+1.18
(n = 5)
57.70+3.72
(n = 5)
33.40+4.02
(n = 5)
7.40+1.11
(n = 5)
DEP/Flu 8.10+1.50
(n = 5)
54.00+4.77
(n = 5)
37.90+4.64
(n = 5)
6.20+0.82
(n = 5)Particle and Fibre Toxicology 2009, 6:22 http://www.particleandfibretoxicology.com/content/6/1/22
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ducted by Chauhan et al. [22]. This study demonstrated
that exposure to the oxidant air pollutant NO2 the week
before the onset of a respiratory virus infection signifi-
cantly increased the severity of the resulting asthma exac-
erbation in a cohort of children. Interestingly, high
exposure to NO2 the week after the onset of the viral infec-
tion was not associated with changes in lower respiratory
tract symptoms or peak expiratory flow measurements
[22]. These data suggest that exposure to NO2 had a prim-
ing effect on the symptoms associated with the subse-
quent naturally acquired viral infection in children with
asthma. Our data presented here show similar results in
that exposure to DEP or infection with influenza alone
did not increase markers of allergic inflammation. Only
animals that were exposed to DEP prior to infection with
influenza showed significant changes in the number of
BALF/lung eosinophils, CCL11, CCR3, or TH2 cytokines,
suggesting that exposure to DEP primed the animals for
virus-induced exacerbation of allergic inflammation.
We found a trend towards increased viral titers 18 hours
post viral inoculation in the DEP-treated groups, at the
Exposure to DEP prior to infection with influenza increases  BALF eosinophils levels in OVA-sensitized mice Figure 3
Exposure to DEP prior to infection with influenza 
increases BALF eosinophils levels in OVA-sensitized 
mice. A.) Total and B.) differential cell count of BAL fluid 
from OVA-sensitized mice exposed to DEP and/or infected 
with influenza A. C.) Representative images of BALF cells in 
obtained from the different experimental groups. *signifi-
cantly different from Sal/Sal control; p < 0.05.
Exposure to DEP prior to infection with influenza increases  tissue eosinophils levels in OVA-sensitized mice Figure 4
Exposure to DEP prior to infection with influenza 
increases tissue eosinophils levels in OVA-sensitized 
mice. Lung sections stained for eosinophils using Carbol 
Chromotrope were analyzed for the presence of perivascu-
lar and peribronchial eosinophils. A.) Average numbers of tis-
sue eosinophils located around small airways (150–200 μm) 
and blood vessels (10–50 μm). B-E.) Representative images 
from an animal exposed to DEP prior to infection with influ-
enza illustrating the number of infiltrated eosinophils around 
the airways and blood vessel. Images illustrating peribronchial 
accumulation of eosinophils (B + C) at 40× (B) and 100× (C) 
magnification and perivascular accumulation of eosinophils 
(D + E) at 40× (D) and 100× (E) magnification. Br = bronchi; 
Ep = epithelium; BV = blood vessel, arrows point to individ-
ual eosinophils. *significantly different from Sal/Sal control; p 
< 0.05.Particle and Fibre Toxicology 2009, 6:22 http://www.particleandfibretoxicology.com/content/6/1/22
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time we observed enhanced allergic inflammation in the
lung. These findings are consistent with previous studies
which have demonstrated at later time points that
repeated exposures to DE, prior to infection with influ-
enza, increase markers of viral replication in epithelial
cells in vitro and in mice in vivo [20,21]. A potential mech-
anism for this enhanced viral replication following DE
exposure is a reduction in the expression of important
antimicrobial defense molecules, a recent observation by
our group [21,26]. The potential clinical significance of
these findings is highlighted by human studies showing a
relationship between TH1/2 immune responses, viral
load, and symptom severity in asthmatic subjects experi-
mentally infected with RV [27].
Whether virus-induced exacerbation of asthma is associ-
ated with an increase in total viral load or a shift in the
location of the infection remains to be determined. For
example, a recent study demonstrated that asthmatics can
harbor RV infection in the lower airways and that this shift
in location of the RV infection is associated with virus-
induced exacerbation of asthma [28]. In addition, another
study demonstrated that the severity of lower respiratory
tract symptoms in subjects diagnosed with a respiratory
virus infection was greater in asthmatics, but that these
effects were not related to the viral load in the upper res-
piratory tract [29]. Thus, we cannot rule out the possibility
that exposure to DEP can modify the distribution of the
viral infection in the lower respiratory tract, and potenti-
ate allergic inflammation by that mechanism.
Recruitment of eosinophils into the lung is regulated by
the expression of specific chemokines such as the eotaxins
(CCL11 and CCL24 in mice), which are selective agonists
for the C-C chemokine receptor 3 (CCR3). Considering
the significant influx of tissue and BALF eosinophils, it is
likely that the enhanced CCR3 we observed in our study
are derived from the increased number of CCR3-express-
ing cells. In addition to observing increased numbers of
CCR3-expressing eosinophils, our data also showed that
exposure to DEP prior to infection with influenza
increases the expression of CCL11. Cellular sources for
CCL11 include endothelial cells, mast cells, fibroblasts,
airway epithelial cells, smooth muscle cells, eosinophils,
and various other cell types. Its expression can be acti-
vated by a number of inflammatory cytokines, such as IL-
1, TNF and IFN [30]. In addition, exposure to DE alone
has been shown to increase the expression of eotaxin in
airway epithelial cells [31] and instillation with DEP
alone or in combination with OVA increased lung eotaxin
levels [32]. However, our data suggest that in mice sensi-
tized and challenges with OVA, a single exposure to DEP
alone is not sufficient to significantly enhance the expres-
sion of eotaxin in the lung. Similarly, only mice exposed
to DEP prior to infection with influenza showed signifi-
cant increases in BALF and tissue eosinophils. Potential
reasons for these differences include the fact that we used
Exposure to DEP prior to infection with influenza increases  markers of eosinophils chemotaxis Figure 5
Exposure to DEP prior to infection with influenza 
increases markers of eosinophils chemotaxis. Total 
mouse lung RNA was analyzed for A.) CCL11 and B.) CCR3 
mRNA levels and normalized to β-actin mRNA levels. *signif-
icantly different from Sal/Sal control; p < 0.05.
Table 2: Lung homogenate cytokine levels
IL-10 IL-1α MCP-1 RANTES
Sal/Sal 0.59 ± 0.15
(n = 11)
1.57 ± 0.26
(n = 11)
6.83 ± 1.41
(n = 11)
9.84 ± 1.80
(n = 11)
DEP/Sal 0.72 ± 0.09
(n = 8)
2.57 ± 0.60
(n = 8)
8.64 ± 1.71
(n = 8)
8.44 ± 1.86
(n = 8)
Sal/Flu 0.66 ± 0.11
(n = 10)
2.46 ± 0.37
(n = 11)
8.80 ± 1.99
(n = 11)
8.83 ± 1.25
(n = 11)
DEP/Flu 0.73 ± 0.12
(n = 10)
3.99 ± 0.96*
(n = 9)
9.08 ± 1.58
(n = 10)
10.70 ± 1.42
(n = 9)
Cytokine levels in whole lung homogenates. Whole lung 
homogenates were analyzed for IL-10, IL-1α, MCP-1, and RANTES. 
Cytokines levels were normalized to lung tissue weight and expressed 
as pg/ml/mg tissue. *significantly different from Sal/Sal control; p < 
0.05Particle and Fibre Toxicology 2009, 6:22 http://www.particleandfibretoxicology.com/content/6/1/22
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a single instillation of DEP shortly after the last OVA chal-
lenge rather than repeated instillations of DEP in combi-
nation with OVA challenge [32]. In addition, the type of
DEP and its chemical characteristics can significantly
affect its ability to potentiate allergic inflammation in
OVA-sensitized mice as has recently been demonstrated
[33]. The authors of that study demonstrated that BALB/c
mice instilled with three chemically distinct DEP samples
during the OVA sensitization phase responded differently
with regards to potentiation of allergic inflammation. Fur-
thermore, we used C57BL/6 mice in the studies presented
here, which are less responsive to OVA-induced allergic
airway inflammation as compared to BALB/c mice [34].
Similarly, DEP-induced exacerbation of allergic inflam-
mation differs among mouse strains [35]. Thus, in addi-
tion to timing of the DEP exposure in relation to
sensitization and/or challenge with OVA, chemical com-
position of the DEP sample as well as mouse strain are
important determinants with regards to DEP-induced
enhancement of allergic inflammation.
A number of studies have shown that IL-1 may play a cen-
tral role during allergic inflammation. For example,
administration of an IL-1 receptor antagonist (IL-1ra)
decreased lung eotaxin levels and infiltration of eosi-
nophils in OVA-sensitized mice [36]. The authors sug-
gested that IL-1 is necessary for allergen-specific TH2 cell
activation and allergic inflammation and that administra-
tion of recombinant IL-1ra decreases allergic inflamma-
tion either directly by inhibiting the pro-inflammatory
activity of IL-1 or indirectly by inhibiting the expression of
IL-5 and eotaxin [36]. Our data indicate that in mice
exposed to DEP prior to infection with influenza, BALF IL-
1 levels were significantly enhanced as compared to the
other groups. Thus, it is conceivable that in animals that
were exposed to DEP prior to infection with influenza, an
increase in IL-1 sets off a cascade culminating in the
enhanced expression of TH2 cytokines and accumulation
of eosinophils in the lung.
Exposure to DEP prior to infection with influenza increases  markers of Th2-type immune response Figure 6
Exposure to DEP prior to infection with influenza 
increases markers of Th2-type immune response. A.) 
Cell-free BALF was analyzed for IL-13 levels. B.) Whole lung 
homogenates were analyzed for IL-4 levels. C.) Total RNA 
isolated from whole lung was analyzed for IL-4rα mRNA lev-
els and normalized to β-actin mRNA levels. *significantly dif-
ferent from Sal/Sal control; p < 0.05.
Table 3: OVA-specific immunoglobulin levels
IgG2c IgE IgG1
Sal/Sal 354.4 ± 108.4
(n = 10)
42973 ± 8680
(n = 11)
384.5 ± 58.54
(n = 10)
DEP/Sal 199.3 ± 51.38
(n = 9)
72669 ± 13391
(n = 8)
428.1 ± 30.89
(n = 9)
Sal/Flu 128.0 ± 38.94
(n = 9)
79598 ± 13747
(n = 10)
488.6 ± 41.34
(n = 11)
DEP/Flu 355.2 ± 131.3
(n = 10)
78654 ± 14977
(n = 10)
434.1 ± 47.33
(n = 10)Particle and Fibre Toxicology 2009, 6:22 http://www.particleandfibretoxicology.com/content/6/1/22
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In conclusion, to our knowledge this is the first study pro-
viding direct experimental evidence that exposure to air
pollutants prior to infection with respiratory virus signifi-
cantly exacerbates allergic airway inflammation. Since
concurrent exposure to air pollutants and infection with
respiratory viruses is likely, these findings could be of sig-
nificant public health implication. This notion is sup-
ported by epidemiological studies demonstrating that
exposure to oxidant air pollutants prior to the onset of a
respiratory virus infection do in fact enhance exacerbation
of asthma in a cohort of children [22]. Future studies are
necessary to further depict the molecular mechanisms by
which exposure to oxidant air pollutants, potentiate virus-
induced exacerbation of allergic inflammation.
Materials and methods
Animals
Similar to our previous studies using influenza virus infec-
tion [37,38] or an ovalbumin sensitization model [39],
male C57BL/6 mice 6–8 weeks old were used throughout
the study. All experimental procedures were approved by
the University of North Carolina IACUC. Based on our
previous studies [39] and as outlined in Fig. 1, mice were
sensitized on days 1 and 2 by i.p. injection of 100 μl of 1%
ovalbumin/alum solution. On days 14, 15, and 16 mice
were challenged with aerosolized ovalbumin (1% wt/v)
for 30 min/day. A minimum of 5 animals were used for
each endpoint.
Oropharyngeal Aspiration of Diesel Exhaust Particles
Diesel exhaust particles (DEP) were kindly provided by
Dr. M. Ian Gilmour and collected as described before [40].
Briefly, a 30-kW (40 hp) four-cylinder Deutz BF4M1008
diesel engine connected to a 22.3-kW Saylor Bell air com-
pressor to provide a load was used to generate the DEP.
The engine and compressor were operated at steady state
to produce 0.8 m3/min of compressed air at 400 kPa. This
translates to ~20% of the engine's full-load rating. Emis-
sions from the engine were diluted with filtered air (3:1)
to near ambient temperatures (~35°C) and directed to a
small baghouse (Dusyex model T6-3.5-9 150 ACFM
pyramidal baghouse using a polyester felt bag). Gram
quantities of DEP were collected from the baghouse using
reverse air pulsing. Once collected, the DEP samples were
stored in sealed containers in a refrigerator (~4°C). For
the exposure, DEP was suspended in sterile HBSS and son-
icated prior to oropharyngeal aspiration of DEP as
described before [41]. Briefly, on day 16 approximately 4
hours after the last OVA challenge, animals were anesthe-
tized using vaporized halothane and suspended on their
incisors. The tongue was distended and a bolus of either
50  μl HBSS vehicle or 25 μg DEP in 50 μl HBSS was
injected onto the oropharynx. Involuntary aspiration was
induced by blocking the animal's nares.
Influenza virus infection
Influenza A/PR/8 (H1N1) was propagated in 10-day-old
embryonated hens' eggs. The virus was collected in the
allantoic fluid and titered by hemagglutination as
described by us before [37,38]. For virus inoculation, mice
were anesthetized with an intraperitoneal injection of ket-
amine (0.022 mg) and xylazine (0.0156 mg) on day 17
(approximately 20 hours after instillation with DEP or
HBSS vehicle) and instilled intranasally with 500 pfu of
influenza virus in 0.05 mL of PBS.
Bronchoalveolar Lavage
Approximately 18 h post infection (on day 18), mice from
each treatment group were euthanized with sodium
pentobarbital and the trachea was exposed, cannulated,
and secured with suture thread. The left mainstem bron-
chus was isolated, clamped with alligator clips after the
trachea was cannulated. The right lungs lobes were lav-
aged 3 times with three volumes of warmed Hanks bal-
anced salt solution (HBSS) (Invitrogen, Grand Island,
NY) (35 ml/kg). The resulting lavage was centrifuged (500
× g, 5 min, 4°C) and cell-free lavage fluid was stored at -
80°C for cytokine measurement. The pelleted cells were
resuspended in 1 ml of RPMI 1640 (Gibco, Carlsbad, CA)
containing 2.5% fetal bovine serum (FBS; Gibco,
Carlsbad, CA). Total cell counts in the lavage fluid of each
mouse were obtained using a hemacytometer. Each sam-
ple (100 and 300 μl) was centrifuged in duplicate onto
slides using a Cytospin (Shandon, Pittsburgh, PA) and
subsequently stained with Diff Quik solution (American
Effects of exposure to DEP on lung viral titers Figure 7
Effects of exposure to DEP on lung viral titers. Whole 
lungs from animals infected with influenza (Sal/Flu and DEP/
Flu) obtained 18 hours post-infection were homogenized and 
analyzed for lung viral titers. Values shown are mean tissue 
culture infectious dose normalized to tissue weight (TCID50/
mg tissue).Particle and Fibre Toxicology 2009, 6:22 http://www.particleandfibretoxicology.com/content/6/1/22
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Scientific, McGraw Park, PA) for cell differentiation deter-
mination, with at least 200 cells counted from each slide.
The left lobe was then removed for RNA, protein isola-
tion, or immunohistochemistry.
Differential Peripheral Blood Leukocyte Count
Blood was collected by cardiac puncture and stored in
EDTA-tubes. Each sample was centrifuged onto slides
using a Cytospin (Shandon, Pittsburgh, PA) and subse-
quently stained with Diff Quik solution (American Scien-
tific, McGraw Park, PA) for cell differentiation
determination, with at least 200 cells counted from each
slide.
Cytokine Measurements
IL-13 concentrations in cell-free bronchoalveolar lavage
(BAL) as well as IL-4, IL-10, IL-1α, MCP-1, and RANTES in
lung homogenates were measured using a Cytokine Fluo-
rescent Bead Immunoassay Assay Kits (Beadlyte®; Milli-
pore, Billerica, MA). Lung homogenates were prepared by
using FastPrep® Lysing Matrix tubes (Millipore). Briefly,
snap-frozen lung tissue was homogenized in HBSS using
the Lysing Matrix D tubes and the Bio101® FastPrep® sys-
tem (MP Biomedicals, Solon, OH). Homogenates were
centrifuged to clear cellular debris and the cytokine levels
were normalized to mg tissue used in the homogenate.
Real Time PCR
Total RNA was extracted from snap-frozen lung tissue
with TRIzol (Invitrogen, Grand Island, NY) as per the sup-
plier's instructions. First strand cDNA synthesis and real-
time RT-PCR were performed as previously described [20]
using commercially available primers and probes
(Applied Biosystems, Foster City, CA).
Histology
Lung tissue samples were fixed in 4% paraformaldehyde
and embedded in paraffin. Five μm thick sections were
placed on Superfrost/plus slides (Fisher Scientific) and
stained using hematoxylin and eosin (H&E; Richard
Allan, Richland, MI) to assess inflammatory infiltrates. To
identify tissue eosinophils, sections were stained using a
Carbol Chromotrope stain, using Chromotrope 2R
(Sigma) dissolved in Phenol. Sections were counter-
stained using hematoxylin and the slides were evaluated
under light microscopy. Five to ten fields of at least 3 ani-
mals per experimental group were evaluated for the H&E
stain. Tissue eosinophils were enumerated by counting
eosinophils surrounding blood vessel and airways using
40× and 100× magnification. Similar to previous reports
[42], at least 5 visual fields with blood vessel (diameter
10–50 μm) or bronchioles (diameter 150–200 μm) per
animal were evaluated for n = 5 animals per experimental
group.
Quantitation of Viral Titers
Lung viral titers were determined by a modified tissue cul-
ture infections dose 50 (TCID50) using hemagglutination
as an endpoint, as previously described [43]. Briefly, snap
frozen lung tissue was weighed and homogenized using
homogenized in minimal essential medium using the Lys-
ing Matrix D tubes and the Bio101® FastPrep® system (MP
Biomedicals, Solon, OH). Samples were centrifuged at
9000 × g for 20 min and the supernatant was serially
diluted starting at 1:5 in MEM containing 20 mg/L trypsin.
Each diluted supernatant (100 μL) was added, in 6 repli-
cates, to 80% confluent MDCK cells and incubated at
37°C for 72 h. A 0.5% suspension of human O RBC (50
μL) was added to each well and incubated at room tem-
perature for 2 h. Viral titer was expressed as the reciprocal
of the highest dilution at which the RBC agglutinated.
This value was then normalized to mg tissue of the sam-
ple.
Analysis of OVA-specific immunoglobulin levels
High binding microplates were coated with 100 μl oval-
bumin (Sigma) in PBS at 1 mg/ml (IgG1 and IgG2c
assays) or 20 mg/ml (IgE assay) at 37°C for 2 hours, fol-
lowed by incubation with 200 μl/well blocking buffer
(1% BSA in PBS) for 1 hour at room temperature. Stand-
ard curves for IgG1 and IgG2c were prepared by diluting
pooled sera that had previously tested as highly concen-
trated in OVA-specific IgG1 or IgG2c. In the IgE assay,
mouse anti-ovalbumin IgE (AbD Serotec, Raleigh, NC)
was used as a standard. One-hundred microliters of each
standard or sample dilution was applied to the wells in
triplicate and incubated overnight at 4°C and 100 μl of
biotinylated anti-Mouse IgG1 (BD Biosciences; 2 ug/ml),
biotinylated anti-Mouse IgG2c (Southern Biotechnology;
1:5000), or biotinylated anti-Mouse IgE (BD Biosciences;
4:1000) was added to each well and incubated at room
temperature for 30 minutes. Streptavidin-HRP (BD Bio-
sciences; 1:1000), was applied to each well and incubated
30 minutes at room temperature, followed by the addi-
tion of TMB substrate (eBioscience). Absorbances were
read at 450 nm and concentrations for IgG1 and IgG2c are
expressed as arbitrary units.
Statistical Analysis
Data are shown as mean ± S.E.M. At least 5 animals per
experimental group were analyzed, although many end-
points were examined in >5 animals. Data were analyzed
using a one-way ANOVA followed by Bonferroni post-hoc
test to determine significant differences among the indi-
vidual groups. A value of p < 0.05 was considered statisti-
cally significant.
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